Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
(OB:
)
N/A
UNCHANGED
Last Price
/ Updated:
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
-
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Performance
Top News
More News
InVivo Therapeutics Announces Froedtert & the Medical College of Wisconsin as New Clinical Trial Site for Neuro-Spinal Scaffold
February 23, 2015
from
Business Wire News Releases
InVivo Therapeutics Appoints Lorianne Masuoka, MD as Chief Medical Officer
February 09, 2015
from
Business Wire News Releases
More News
Read More
InVivo Therapeutics Announces CEO Mark Perrin Named Chairman of the Board
February 05, 2015
from
Business Wire News Releases
InVivo Therapeutics Announces $12 Million Registered Direct Offering
January 29, 2015
from
Business Wire News Releases
InVivo Therapeutics Announces Enrollment of Second Subject in Pilot Spinal Cord Injury Trial
January 22, 2015
from
Business Wire News Releases
InVivo Therapeutics Reports Three-Month Update of First Acute Spinal Cord Injury Subject Implanted with Neuro-Spinal Scaffold
January 21, 2015
from
Business Wire News Releases
InVivo Therapeutics Announces Reopening of Enrollment for Ongoing Pilot Trial
January 09, 2015
from
Business Wire News Releases
Medical Device Makers Are Cheering After Latest Victory from GOP
November 14, 2014
from
ACCESSWIRE
InVivo Therapeutics Announces FDA Approval to Expedite Enrollment for Ongoing Pilot Trial
December 16, 2014
from
Business Wire News Releases
InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc.
October 22, 2014
from
PR Newswire
InVivo Therapeutics Announces University of Pittsburgh Medical Center Presbyterian as New Clinical Trial Site for Neuro-Spinal Scaffold
November 25, 2014
from
Business Wire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates
Bots go here